BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10732714)

  • 1. Enhanced IL-10 and decreased IL-2 production after orthotopic corneal transplantation in mice.
    Hasková Z; Filipec M; Holán V
    Folia Biol (Praha); 1999; 45(1):21-5. PubMed ID: 10732714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine expression during orthotopic corneal allograft rejection in mice.
    Sano Y; Osawa H; Sotozono C; Kinoshita S
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1953-7. PubMed ID: 9727419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice.
    Hasková Z; Filipec M; Holán V
    Folia Biol (Praha); 1996; 42(3):105-11. PubMed ID: 8971221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical role of lymph nodes in corneal alloimmunization and graft rejection.
    Yamagami S; Dana MR
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1293-8. PubMed ID: 11328742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J; Joyce NC; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL; Mayhew E; Hegde S; Niederkorn J
    Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
    Qian Y; Boisgerault F; Benichou G; Dana MR
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection.
    Amescua G; Collings F; Sidani A; Bonfield TL; Rodriguez JP; Galor A; Medina C; Yang X; Perez VL
    Transplantation; 2008 Feb; 85(4):615-25. PubMed ID: 18347542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.